La Jolla Pharmaceutical Future Growth
Future criteria checks 4/6
La Jolla Pharmaceutical is forecast to grow earnings and revenue by 59% and 19.8% per annum respectively while EPS is expected to grow by 55.8% per annum.
Key information
59.0%
Earnings growth rate
55.8%
EPS growth rate
| Biotechs earnings growth | 24.7% |
| Revenue growth rate | 19.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Innoviva to acquire La Jolla Pharma for $149M including debt
Jul 11We Think La Jolla Pharmaceutical's (NASDAQ:LJPC) Robust Earnings Are Conservative
Nov 11
Our Take On La Jolla Pharmaceutical Company
Jul 02La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue
May 07La Jolla Pharmaceutical's (NASDAQ:LJPC) Shareholders Are Down 82% On Their Shares
Mar 11Market Sentiment Around Loss-Making La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Feb 11Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18%
Jan 16La Jolla Pharmaceutical rallies on exclusive licensing agreement with PAION
Jan 12Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?
Jan 05Could The La Jolla Pharmaceutical Company (NASDAQ:LJPC) Ownership Structure Tell Us Something Useful?
Dec 09La Jolla Pharmaceutical EPS beats by $0.11, beats on revenue
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 77 | 16 | N/A | N/A | 1 |
| 12/31/2023 | 64 | 8 | N/A | N/A | 1 |
| 12/31/2022 | 47 | 1 | N/A | N/A | 1 |
| 6/30/2022 | 46 | 4 | 13 | 13 | N/A |
| 3/31/2022 | 52 | 5 | 14 | 14 | N/A |
| 12/31/2021 | 76 | 20 | 28 | 28 | N/A |
| 9/30/2021 | 74 | 12 | 18 | 18 | N/A |
| 6/30/2021 | 70 | 3 | 7 | 7 | N/A |
| 3/31/2021 | 60 | -16 | -8 | -8 | N/A |
| 12/31/2020 | 33 | -39 | -38 | -38 | N/A |
| 9/30/2020 | 30 | -61 | -48 | -47 | N/A |
| 6/30/2020 | 26 | -79 | -57 | -56 | N/A |
| 3/31/2020 | 26 | -93 | -65 | -65 | N/A |
| 12/31/2019 | 23 | -117 | -86 | -85 | N/A |
| 9/30/2019 | 20 | -137 | -101 | -100 | N/A |
| 6/30/2019 | 18 | -158 | -119 | -118 | N/A |
| 3/31/2019 | 14 | -181 | -141 | -139 | N/A |
| 12/31/2018 | 10 | -199 | -155 | -152 | N/A |
| 9/30/2018 | 6 | -193 | -153 | -146 | N/A |
| 6/30/2018 | 2 | -168 | -136 | -127 | N/A |
| 3/31/2018 | 1 | -142 | -118 | -109 | N/A |
| 12/31/2017 | N/A | -115 | -94 | -85 | N/A |
| 9/30/2017 | 0 | -101 | -83 | -78 | N/A |
| 6/30/2017 | 0 | -96 | -78 | -75 | N/A |
| 3/31/2017 | 0 | -85 | -70 | -68 | N/A |
| 12/31/2016 | 1 | -78 | -61 | -59 | N/A |
| 9/30/2016 | 1 | -65 | -50 | -49 | N/A |
| 6/30/2016 | 2 | -54 | -40 | -39 | N/A |
| 3/31/2016 | 1 | -49 | N/A | -33 | N/A |
| 12/31/2015 | 1 | -42 | N/A | -25 | N/A |
| 9/30/2015 | 1 | -37 | N/A | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LJPC's forecast earnings growth (59% per year) is above the savings rate (1.9%).
Earnings vs Market: LJPC's earnings (59% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: LJPC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LJPC's revenue (19.8% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: LJPC's revenue (19.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LJPC's Return on Equity is forecast to be high in 3 years time